Net Income - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Net Income
-$59.6m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$38B
CAGR 3-Years
29%
CAGR 5-Years
18%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$6.5B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$13.8B
CAGR 3-Years
55%
CAGR 5-Years
8%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Net Income
$7.3B
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
8%

See Also

What is Xeris Biopharma Holdings Inc's Net Income?
Net Income
-59.6m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Net Income amounts to -59.6m USD.

What is Xeris Biopharma Holdings Inc's Net Income growth rate?
Net Income CAGR 5Y
9%

Over the last year, the Net Income growth was 17%. The average annual Net Income growth rates for Xeris Biopharma Holdings Inc have been 11% over the past three years , 9% over the past five years .

Back to Top